nivolumab,ipilimumab
bms
['nivo', 'rcc,(-irccs),(-srcc),(-urcc)', '/ipi']
triple therapy in #nccrcc? final results of #cani trial: triple therapy w/ cabo/nivo/ipi in pts with nccrcc
-safety concern: 74% g3-4 ae (10% cardiac)
-cr: 0%
-orr all/1l: 18/21%
-mpfs 8.9m
-mos nr, 12m os 79% #asco23 ?doublet&gt;triplet 
Medical oncologist @GACancerCenter, Augusta University specializing in genitourinary &breast oncology. Editor and TB moderator @themednet.org #patientadvocate